Switch theme
Sign up to access all valuation multiples
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
1984
40.1K+
LTM Revenue $5.6B
LTM EBITDA $1.1B
$14.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Encompass Health has a last 12-month revenue (LTM) of $5.6B and a last 12-month EBITDA of $1.1B.
In the most recent fiscal year, Encompass Health achieved revenue of $5.4B and an EBITDA of $1.2B.
Encompass Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Encompass Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $5.6B | XXX | $5.4B | XXX | XXX | XXX |
| Gross Profit | $5.6B | XXX | $2.2B | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 42% | XXX | XXX | XXX |
| EBITDA | $1.1B | XXX | $1.2B | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 22% | XXX | XXX | XXX |
| EBIT | $822M | XXX | $865M | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $479M | XXX | $456M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $2.4B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Encompass Health's stock price is $121.
Encompass Health has current market cap of $12.2B, and EV of $14.8B.
See Encompass Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14.8B | $12.2B | XXX | XXX | XXX | XXX | $4.67 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Encompass Health has market cap of $12.2B and EV of $14.8B.
Encompass Health's trades at 2.8x EV/Revenue multiple, and 12.5x EV/EBITDA.
Equity research analysts estimate Encompass Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Encompass Health has a P/E ratio of 25.4x.
See valuation multiples for Encompass Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $12.2B | XXX | $12.2B | XXX | XXX | XXX |
| EV (current) | $14.8B | XXX | $14.8B | XXX | XXX | XXX |
| EV/Revenue | 2.6x | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | 12.9x | XXX | 12.5x | XXX | XXX | XXX |
| EV/EBIT | 18.0x | XXX | 17.1x | XXX | XXX | XXX |
| EV/Gross Profit | 2.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 25.4x | XXX | 26.7x | XXX | XXX | XXX |
| EV/FCF | 25.2x | XXX | 41.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEncompass Health's last 12 month revenue growth is 9%
Encompass Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $34K for the same period.
Encompass Health's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Encompass Health's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Encompass Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| Rule of 40 | 30% | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 43% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $34K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Encompass Health acquired XXX companies to date.
Last acquisition by Encompass Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Encompass Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Encompass Health founded? | Encompass Health was founded in 1984. |
| Where is Encompass Health headquartered? | Encompass Health is headquartered in United States of America. |
| How many employees does Encompass Health have? | As of today, Encompass Health has 40.1K+ employees. |
| Who is the CEO of Encompass Health? | Encompass Health's CEO is Mr. Mark J. Tarr. |
| Is Encompass Health publicy listed? | Yes, Encompass Health is a public company listed on NYS. |
| What is the stock symbol of Encompass Health? | Encompass Health trades under EHC ticker. |
| When did Encompass Health go public? | Encompass Health went public in 1989. |
| Who are competitors of Encompass Health? | Similar companies to Encompass Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Encompass Health? | Encompass Health's current market cap is $12.2B |
| What is the current revenue of Encompass Health? | Encompass Health's last 12 months revenue is $5.6B. |
| What is the current revenue growth of Encompass Health? | Encompass Health revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Encompass Health? | Current revenue multiple of Encompass Health is 2.6x. |
| Is Encompass Health profitable? | Yes, Encompass Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Encompass Health? | Encompass Health's last 12 months EBITDA is $1.1B. |
| What is Encompass Health's EBITDA margin? | Encompass Health's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Encompass Health? | Current EBITDA multiple of Encompass Health is 12.9x. |
| What is the current FCF of Encompass Health? | Encompass Health's last 12 months FCF is $587M. |
| What is Encompass Health's FCF margin? | Encompass Health's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Encompass Health? | Current FCF multiple of Encompass Health is 25.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
